source
- Final Medicare rule to curb doctor-administered drug prices covers only four firms, delivering far less savings than proposedThe Trump administration released a final rule intended to lower Medicare prices for drugs given in doctors' offices. The rule applies only to four pharmaceutical companies, a far narrower scope t…
- UniQure’s Huntington’s gene therapy shows reduced benefit in fourth year, but patient remains optimisticUniQure reported new data on its experimental Huntington’s disease gene therapy, AMT-130, in a four‑year follow‑up of 12 patients. The update showed the treatment slowed disease progression by 44%,…